2 news items
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
EXAS
24 May 24
of 21-gene assay to assess breast cancer-specific mortality and benefit of chemotherapy by race and ethnicity
Exact Sciences Announces First-Quarter 2024 Results
EXAS
8 May 24
new products and services and assess potential market opportunities; our ability to effectively enter into and utilize strategic partnerships
- Prev
- 1
- Next